Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Patients-Warfarin'
Patients-Warfarin published presentations and documents on DocSlides.
NOACs vs. warfarin: Pros and Cons for Patients and Providers to Consider
by debby-jeon
Advantages of NOACs. No INR monitoring required. ...
FOR INJECTION Warfarin sodium can cause majoeeding is more likely to
by valerie
1 COUMADIN Tablets for oralLactose, starch an...
Warfarin Therapy
by ellena-manuel
Nicolas Novitzky. The Ideal Oral Anticoagulant. I...
Constipation Warfarin Orders
by ruby
Oliguria. Hypoxia. Tachycardia. Cover Shifts part ...
Warfarin Sodium (Anticoagulant)
by lucy
Therapy Training. 03/10/2015. Objectives. 1. What ...
Consistent with Fetal Warfarin SyndromeTheera Tongsong MD Chanane Wa
by mila-milly
Received January 25, 1999, from the Department of ...
Coumadin Warfarin OrdersComplete form once at beginning of therapy
by finley
Indication and Target INRAtrial Fibrillation / Atr...
P erioperative management of anticoagulated geriatric patients with
by TinyTeddy
hip fractures. Dr Linda Xu . linda.xu@health.nsw.g...
Dos and Don’ts for High-Risk Elderly Patients With AF
by ellena-manuel
Why Anticoagulate?. Anticoagulate Even in High-Ri...
Maintaining patients on anticoagulants: how to do it
by olivia-moreira
د. ØØ³ÙŠÙ† Ù…ØÙ…د جمعة . اختصاØ...
Dabigatran in Asia RE-LY Asia analysis and real world evidences from Asia
by adah
NOAC vs Warfarin Atrial Fibrillation Studies – A...
The Canadian Journal of CME June 2003
by evans
atrophiclichen sclerosusWhat is the difference bet...
Review on NOACs Studies Dr.
by BlessedBeyondMeasure
Kourosh. . Sadeghi. Tehran University of medical ...
ADAS Anticoagulant Dosing and Advisory Service
by maddoxjustin
Sean O’Brien. ADAS Deputy Manager. Bev . Straker...
Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents
by danika-pritchard
Introduction/Overview . VKA-Associated Bleeding: ...
Pharmacologic and Nonpharmacologic Treatments of Atrial Fibrillation
by kittie-lecroy
Martha Drake MS, FNP-BC. Chicago Heart and Vascul...
Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage
by faustina-dinatale
Fred V. Plapp MD PhD. Pathology and Laboratory Me...
Safety and Efficacy of Uninterrupted Anticoagulation with
by olivia-moreira
Dabigatran . Etexilate versus Warfarin in Patient...
R eal-world
by liane-varnes
EVI. dence. on . S. troke prevention . I. n pati...
Dodson Thompson, DO
by lois-ondreau
Northlakes. Community Clinic. Minong, WI. Novel ...
Percutaneous Closure of the Left Atrial Appendage
by cheryl-pisano
versus Warfarin Therapy for Prevention of Stroke ...
Antiphospholipid Syndrome
by walsh
WHAT’S NEW?. Savino . Sciascia. , MD, PhD. Cente...
Market ApplicabilityEffective Date
by isabella2
Market FL & FHK FL MMA FL LTC GA KS KY LA MD NJ ...
New (Direct)Oral anti-coagulants in the treatment of VTE
by ariel
Dr NA Smith - Haematology Dept. Heart of England...
Drugs used for Thrombosis
by dora
Thrombotic . or thromboembolic disease is common a...
WA Adult Anticoagulation
by elizabeth
Medication . Chart. Overview. This presentation wi...
Nonvalvular Atrial Fibrillation Anticoagulation Colour Comparison Ch
by daniella
www.RxFiles.ca June 2021 Drug / BRAND Vitamin K ...
Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know
by dsuser1
Christopher Granger, . MD. Sean Pokorney, MD. . D...
Disclaimer The Canadian Cardiovascular Society (CCS) welcomes reuse of our educational slide deck f
by tatiana-dople
www.onlinecjc.com. ). . Â . If your reuse request...
A New Era in Anticoagulation Management
by alexa-scheidler
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Journal Club Jim Hoehns,
by cheryl-pisano
Pharm.D. .. Edoxaban. Oral factor . Xa. inhibito...
Watchman II: PROTECT AF/PREVAIL
by sherrill-nordquist
Meta-Analysis and Implications . David R. Holmes,...
ANTICOAGULATION Blake Wachter
by olivia-moreira
, MD, PhD . Monday Morning Conference. Oct 4, 201...
Watchman II: PROTECT AF/PREVAIL
by debby-jeon
Meta-Analysis and Implications . David R. Holmes,...
WATCHMANâ„¢ Left Atrial Appendage Closure Device
by alexa-scheidler
www.watchmandevice.com. AF is a Growing Problem A...
Update on the New Oral Anticoagulants
by sherrill-nordquist
Eliot Williams, MD PhD. Division of Hematology &a...
A New Era in Anticoagulation Management
by debby-jeon
Allyson Sarigianis, Pharm.D.. October 19, 2013. O...
Novel Oral Anticoagulants
by natalia-silvester
(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...
Management of
by marina-yarberry
Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...
A RARE CAUSE OF CVT CLINICAL CLUB
by finley
M3 UNIT. DR IBRAHIM ALI SALEEM. THE CASE SUMMARY. ...
Load More...